Tijdschrift voor Geneeskunde ASBL
1.4 FTETijdschrift voor Geneeskunde reported revenue of 154,659 € for the 2025 financial year (annual accounts filed with the NBB on 28 May 2026), with 1.4 full-time equivalent.
By total assets for 2025, Tijdschrift voor Geneeskunde ranks among the 50 largest of the 149 companies in its sector (NACE 5813) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Tijdschrift voor Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -25 % Equity -36 % Total assets -35 % Headcount (avg FTE) -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tijdschrift voor Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 154,659 € | ||||
| Net result | −121,534 € | ||||
| Equity | 791,357 € | ||||
| Cash | 50,967 € | ||||
| EBITDA | −110,085 € | ||||
| Total assets | 894,790 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 25 May 2023
- Year ended 31 Dec 2021filed on 07 Oct 2022
Tijdschrift voor Geneeskunde's financial analysis
- Solvency88.4%sector median: 45.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tijdschrift voor Geneeskunde
9 active director(s) in the register.
and 3 more
Tijdschrift voor Geneeskunde's shareholders and holdings →Tijdschrift voor Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0410.801.631
- VAT number
- BE0410801631
- Peppol
- Registered · 0208:0410801631 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 04 Jun 1962
- Registered office
- 3001 Leuven
- Size
- Micro · 1.4 FTE
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Publishing of journals and periodicals (NACE 58130)
Tijdschrift voor Geneeskunde (ASBL) has been based in Leuven since 1962, active in: publishing of journals and periodicals. For 2025, it reports revenue of 154,659 €, a net loss of 121,534 € and equity of 791,357 €. With 1.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 88.4%, above the median of its sector (45.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Tijdschrift voor Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- EOS Wetenschap Publishing of journals and periodicals Antwerp · balance sheet 922,509 €
- Association pour la Promotion des Editions en Faveur des Classes Moyennes Publishing of journals and periodicals Evere · balance sheet 533,328 €
- Ons Erfdeel Publishing of journals and periodicals Ghent · balance sheet 987,493 €
- Industrie des Vernis, Peintures, Mastics, Encres d'Imprimerie et Couleurs d'Art Publishing of journals and periodicals Schaerbeek · balance sheet €1.64m
- STEUNBEER uitgeverij Publishing of books Holsbeek · balance sheet 14,783 €
- CFC-Editions Publishing of books Brussels · balance sheet 944,117 €
Frequently asked questions about Tijdschrift voor Geneeskunde
What is the revenue of Tijdschrift voor Geneeskunde?
According to the 2025 annual accounts filed with the NBB, the revenue of Tijdschrift voor Geneeskunde amounts to 154,659 €.
What is the VAT number of Tijdschrift voor Geneeskunde?
In Belgium, the VAT number is the company number prefixed with BE: BE0410801631 for Tijdschrift voor Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0410.801.631.
Where is the registered office of Tijdschrift voor Geneeskunde?
According to the CBE register, the registered office of Tijdschrift voor Geneeskunde is in 3001 Leuven.
What is the equity of Tijdschrift voor Geneeskunde?
At the close of the 2025 financial year, the equity of Tijdschrift voor Geneeskunde amounts to 791,357 €, a solvency of 88.4% of total assets.
How many people work at Tijdschrift voor Geneeskunde?
1.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tijdschrift voor Geneeskunde?
The register lists 9 active mandates at Tijdschrift voor Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Tijdschrift voor Geneeskunde within its sector?
By total assets for 2025, Tijdschrift voor Geneeskunde ranks among the 50 largest of the 149 companies in its sector (NACE 5813) in Belgium that filed accounts for that financial year.
The full file of Tijdschrift voor Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →